BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG (BPMUF) Stock Price, Quote, News & History

BPMUFOTCPK

Trade with Public

$60.27

Last update: Jun 10, 12:32 PM

OverviewNews Short Interest

Key Statistics

Open

Volume / Avg.

0 / 15.00

Day Range

- - -

52 Wk Range

59.29 - 74.00

Market Cap

P/E Ratio

15.25

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

585.5

Recent Basilea Pharmaceutica AG Allschwil News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

62.09M

Investing Cash Flow (TTM)

-2.86M

Financing Cash Flow (TTM)

-21.43M

Free Cash Flow (TTM)

59.23M

Capital Expenditure (TTM)

-2.86M

Net Change in Cash (TTM)

37.80M

Valuation Metrics

Enterprise Value

$697.34M

PE Ratio (TTM)

15.25

PE Ratio (FWD)

6.87

PEG Ratio (TTM)

PS Ratio (TTM)

2.82

PB Ratio (TTM)

4.63

Earnings Yield % (TTM)

6.56%

Earnings Yield % (FWD)

14.55%

EV / EBITDA (TTM)

10.84

Price / EBITDA (TTM)

12.84

Price / Free Cash Flow (TTM)

11.07

Book Value / Share

$13.01

Company Debt

Total Debt

$75.44M

LT Debt

$75.44M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$22.04M

Total Cash

$159.80M

Debt to Equity

0.70

Issuance of Debt (TTM)

-$22.04M

Repayment of Debt (TTM)

-$22.04M

Key Statistics

Open

Volume / Avg.

0 / 15.00

Day Range

- - -

52 Wk Range

59.29 - 74.00

Market Cap

P/E Ratio

15.25

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

585.5

About

Sector

Health Care

Industry

Biotechnology

Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG (BPMUF) stock?

You can purchase shares of BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG (OTCPK:BPMUF) through any online brokerage.

View our list of the best stock brokerages

Who are BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG (BPMUF) competitors?

There are no as such competitors for BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG.

What is the forecast, or price target, for BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG (BPMUF) stock?

There is no analysis for BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG to provide a consensus price target.

What is the current price for BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG (BPMUF)?

The stock price for BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG (OTCPK: BPMUF) is $60.275 last updated June 10, 2026 at 12:32 PM EDT.

Does BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG (BPMUF) pay a dividend?

There are no upcoming dividends for BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG.

When is BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG (OTCPK:BPMUF) reporting earnings?

BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG does not have any upcoming earnings scheduled.

Is BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG (BPMUF) going to split?

There is no upcoming split for BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG.

What sector and industry does BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG (BPMUF) operate in?

BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.